- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Genmed Holding Corp
+ Add to WatchlistGENM:US
0.0070 USD 0.0010 12.50%As of 20:10:00 ET on 05/20/2013.
Snapshot for Genmed Holding Corp (GENM)
| Open: | 0.0050 | Day's Range: | 0.0050 - 0.0070 | Volume: | 10,200 |
|---|---|---|---|---|---|
| Previous Close: | 0.0080 | 52wk Range: | 0.0002 - 0.0300 | 1-Yr Rtn: | -65.00% |
Key Statistics for GENM
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.0100 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 2.06 |
| Shares Outstanding (M) | 294.88 |
| 30 Day Average Volume | 19,120 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 899.7941 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/28/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GENM
Company Profile & Key Executives for GENM
Genmed Holding Corporation, through its subsidiary, is developing and seeking a network of manufacturing and distribution relationships in The Netherlands, Romania, South America, the United States, and the United Kingdom to supply generic drugs to retail chains.
| Erwin R BouwensChairman/President/CEO | Randy HibmaVice President/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
GENM News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page